FectoVIR®-AAV Transfection Reagent for rAAV Production in Suspension, Polyplus-transfection
Next generation of transfection reagent for rAAV production in suspension.
- High performance: Superior yield for AAV production
- Scalability: Developed for small to large scale manufacturing
- Flexibility: Compatible with commercial culture media
- Trustworthy: #1 transfection supplier of gene and cell therapy
- GMP compliance: GMP grade coming soon
FectoVIR®-AAV is a novel class of animal-free transfection reagent specifically developed for research development up to industrial scale production of recombinant AAV (rAAV) viral vectors in suspension HEK-293 cell types.
FectoVIR®-AAV transfection reagent guarantees higher rAAV viral titers, improved flexibility and scalability for industrial scale manufacturing.
: Since 2002, Polyplus-transfection® is ISO 9001 certified and since then this certification has been successfully renewed every three years.
- Environmentally Preferable: